IntrinsicIntrinsic
← Scroll for more →

Financial Statements — DCX

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023
Cash & Equivalents3.940.353.711.0710.73
Short-term Investments--40.26------
Inventory--10.0311.1516.7214.79
Total Current Assets866.68113.2662.4277.7290.83
Property, Plant & Equipment--150.70155.82166.41181.38
Goodwill--2.672.622.632.70
Intangible Assets--0.000.000.020.03
Total Non-current Assets*0.20377.66408.37422.59445.62
Total Assets866.68490.91470.79500.31536.45
Total Current Liabilities709.20584.08573.31523.61525.05
Total Non-current Liabilities*0.0073.1242.9685.1190.27
Total Liabilities709.20657.20616.27608.72615.33
Retained Earnings(370.99)(401.18)(361.13)(335.86)(314.23)
Total Stockholder Equity150.97(179.58)(179.27)(153.99)(132.83)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024
Total Revenue0.603.41
Cost of Revenue6.587.57
Gross Profit(7.16)(12.33)
Research & Development0.161.08
Selling, General & Admin60.6012.84
Total Operating Expenses61.1614.65
Operating Income(68.32)(26.98)
Interest Expense8.20--
Pretax Income(61.49)(31.52)
Net Income(40.05)(21.62)
Basic EPS(276.80)(628.80)
Diluted EPS(276.80)(628.80)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024
Operating Cash Flow1.62(16.26)
Capital Expenditures--1.06
Free Cash Flow*--(17.32)
Investing Cash Flow(0.26)(1.06)
Financing Cash Flow(1.79)3.16
← Scroll for more columns →

* Derived from reported values